Laos launches Molacovir drug to treat 

Manage your play funds in order Youslotxo walletshouldn't bring the benefits of coming to play because it may cause you not to see the cost of money and the benefits of playing with that day you have no benefit I couldn't get it. Because you have already made all the bets. For players with limited funds We recommend getting free credits from the SLOTXO promotion to increase your investment as much as possible. 

COVID-19 patients in the early stages Ready to sell and used. Price is 30 baht per 1 capsule.

On January 4, 2022, Matichon reported, according to the Vientiane Times, that State-owned drug manufacturing company No. 3, a state-owned enterprise factory of Vietnam, has produced a drug known as Molacovir, a pill used to treat COVID-19 The initial stage is now available for sale and applied to patients.

The report states that molacovir is the commercial name used in Laos. It is the same drug as "Molnupiravir" that was originally used to treat "Influenza" developed by Emory University. in the United States before the company "Ridgeback Biotherapeutics" in partnership with Merck will receive the right to develop a drug to treat COVID-19 patients at a later date.

The Lao government has the right to produce commercially. And it was approved for production in November. and actually started production in December last

Recently, Laos can produce pills. Molacovir is sufficient to treat about 1,000 COVID-19 patients, with all production, including pilot clinical trials, under the supervision of the World Health Organization.